Kyverna Therapeutics, Inc. - Common Stock (NQ:KYTX)

6.230 +0.010 (+0.16%)

Delayed Quote Updated: 11:27 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kyverna Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

KYTX Stock Earnings: Kyverna Therapeutics Misses EPS for Q1 2024 ↗

May 14, 2024

KYTX stock results show that Kyverna Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 01, 2024

Via Benzinga

Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys? ↗

February 25, 2024

The market's excited for these stocks, but there's no rush to buy them.

Via The Motley Fool

Topics Initial Public Offering

Gilead-Backed Kyverna Overshoots Raised IPO Expectations ↗

February 11, 2024

Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a...

Via Talk Markets

Topics Initial Public Offering

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.